Sources of IL-6 do not have to be limited to the tumour microenvironment (TME) but can also be produced by hematopoietic stem and progenitor cells (HPSC), epithelial cells, or muscle tissue, all contributing to the rigorous inter-cellular cross-talk, vital for the advancement of the disease [8,9]. The gene discussed is IL6; the disease is neoplasm.